[Epidemiology of age related macular degeneration].
暂无分享,去创建一个
E. Souied | G. Soubrane | G. Coscas | C. Delcourt | H. Dollfus | J. Zerbib | N. Leveziel | P. Benlian | J. Kaplan
[1] M. Brantley,et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy , 2009, Eye.
[2] N. Cheung,et al. Method to increase the sensitivity of perimetric trend progression analysis , 2008, British Journal of Ophthalmology.
[3] R. Klein,et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. , 2008, Archives of ophthalmology.
[4] P. Mitchell,et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. , 2008, Ophthalmology.
[5] P. D. de Jong,et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. , 2008, The American journal of clinical nutrition.
[6] C. Klinge,et al. Resveratrol stimulates nitric oxide production by increasing estrogen receptor αa‐Src‐caveolin‐1 interaction and phosphorylation in human umbilical vein endothelial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] T. Wong,et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. , 2008, Archives of ophthalmology.
[8] A. Fletcher,et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. , 2008, Ophthalmology.
[9] A. Luff,et al. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment , 2008, Eye.
[10] J. Ott,et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.
[11] Julie A Simpson,et al. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. , 2008, American journal of ophthalmology.
[12] T. Peto,et al. Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland. The Greenland Inuit Eye Study. , 2008, Ophthalmology.
[13] R. Klein,et al. Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. , 2008, American journal of ophthalmology.
[14] P. Mitchell,et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2008, Ophthalmology.
[15] M. Brantley,et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. , 2007, Ophthalmology.
[16] T. Ianchulev,et al. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients. , 2007, Ophthalmology.
[17] R. Lamuela-Raventós,et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. , 2007, The American journal of clinical nutrition.
[18] F. Ferris,et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. , 2007, Archives of ophthalmology.
[19] P. Mitchell,et al. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2007, Ophthalmology.
[20] B. Rosner,et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.
[21] J. Ott,et al. The LOC387715 Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration , 2007, Human Heredity.
[22] G. Murthy,et al. Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. , 2007, Investigative ophthalmology & visual science.
[23] R. Klein,et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. , 2007, American journal of ophthalmology.
[24] P. Bernstein,et al. Evaluation of 4-Methylpyrazole as a Potential Therapeutic Dark Adaptation Inhibitor , 2007, Current eye research.
[25] K. Gawrisch,et al. Evidence for Specificity in Lipid-Rhodopsin Interactions* , 2006, Journal of Biological Chemistry.
[26] R. Klein,et al. Age-Related Macular Degeneration and Risk for Stroke , 2006, Annals of Internal Medicine.
[27] B. Rosner,et al. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. , 2006, Archives of ophthalmology.
[28] P. Barberger‐Gateau,et al. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. , 2006, Investigative ophthalmology & visual science.
[29] Usha Chakravarthy,et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). , 2006, Archives of ophthalmology.
[30] Alan Grossfield,et al. A role for direct interactions in the modulation of rhodopsin by ω-3 polyunsaturated lipids , 2006 .
[31] A. Hofman,et al. Dietary intake of antioxidants and risk of age-related macular degeneration. , 2005, JAMA.
[32] D. Clayton,et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation , 2005, British Journal of Ophthalmology.
[33] T. Das,et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. , 2005, Investigative ophthalmology & visual science.
[34] S. Fisher,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .
[35] C. Delcourt,et al. The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study. , 2005, American journal of ophthalmology.
[36] Y. Nose,et al. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. , 2005, Investigative ophthalmology & visual science.
[37] T. Clemons,et al. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. , 2004, Archives of ophthalmology.
[38] Frank A Sloan,et al. Longitudinal prevalence of major eye diseases. , 2003, Archives of ophthalmology.
[39] R. Willke,et al. Incidence of exudative age-related macular degeneration among elderly Americans. , 2003, Ophthalmology.
[40] David I W Phillips,et al. Lutein and zeaxanthin status and risk of age-related macular degeneration. , 2003, Investigative ophthalmology & visual science.
[41] B. Rosner,et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. , 2003, Archives of ophthalmology.
[42] A. Bird,et al. The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study. , 2003, Acta ophthalmologica Scandinavica.
[43] T. Peto,et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.
[44] Johanna M Seddon,et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.
[45] Paul Mitchell,et al. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. , 2003, Archives of ophthalmology.
[46] Ronald Klein,et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.
[47] Y. Nose,et al. Risk factors for age related maculopathy in a Japanese population: the Hisayama study , 2003, The British journal of ophthalmology.
[48] D. C. Mitchell,et al. Enhancement of G protein-coupled signaling by DHA phospholipids , 2003, Lipids.
[49] P. Mitchell,et al. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[50] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[51] P. Mitchell,et al. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. , 2002, Archives of ophthalmology.
[52] S. Resnikoff,et al. Visual impairment and blindness in Europe and their prevention , 2002, The British journal of ophthalmology.
[53] B. Sumpio,et al. Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. , 2002, Journal of vascular surgery.
[54] Paul Mitchell,et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[55] R. Klein,et al. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. , 2001, Archives of ophthalmology.
[56] C. Delcourt,et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. , 2001, Archives of ophthalmology.
[57] Y. Kiyohara,et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study , 2001, The British journal of ophthalmology.
[58] R. Glynn,et al. Body mass index and the incidence of visually significant age-related maculopathy in men. , 2001, Archives of ophthalmology.
[59] W. Willett,et al. Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.
[60] E. Rimm,et al. Prospective study of zinc intake and the risk of age-related macular degeneration. , 2001, Annals of epidemiology.
[61] A Hofman,et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.
[62] R. Klein,et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. , 2001, American journal of epidemiology.
[63] C. Delcourt,et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study , 2001, Ophthalmic epidemiology.
[64] A. Simopoulos. Human requirement for N-3 polyunsaturated fatty acids. , 2000, Poultry science.
[65] C. Delcourt,et al. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age. , 1999, Archives of ophthalmology.
[66] R. Klein,et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. , 1999, Archives of ophthalmology.
[67] S C Jensen,et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.
[68] Annette Ostenfeld‐Åkerblom. Age-related macular degeneration in Inuit. , 1999, Acta ophthalmologica Scandinavica.
[69] C. Delcourt,et al. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. , 1998, Archives of ophthalmology.
[70] S. Nigdikar,et al. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. , 1998, The American journal of clinical nutrition.
[71] R. Klein,et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. , 1998, American journal of epidemiology.
[72] C. Duijn,et al. Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.
[73] A. Munnich,et al. The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .
[74] J. C. Smith,et al. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. , 1997, Analytical chemistry.
[75] W. Willett,et al. A prospective study of cigarette smoking and age-related macular degeneration in women. , 1996, JAMA.
[76] R. Klein,et al. Smoke gets in your eyes too. , 1996, JAMA.
[77] R J Glynn,et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.
[78] M. C. Leske,et al. Features of Age-Related Macular Degeneration in a Black Population , 1995 .
[79] E. Diamandis,et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.
[80] Lawrence A. Yannuzzi,et al. Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .
[81] R Hiller,et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.
[82] B Rosner,et al. Vitamin A supplementation for retinitis pigmentosa. , 1993, Archives of ophthalmology.
[83] F. Khachik,et al. Separation, identification, and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromatography , 1991 .
[84] T. Rosenberg. Prevalence of blindness caused by senile macular degeneration in Greenland. , 1987, Arctic medical research.
[85] D M Snodderly,et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. , 1984, Investigative ophthalmology & visual science.
[86] F. Delori,et al. The macular pigment. II. Spatial distribution in primate retinas. , 1984, Investigative ophthalmology & visual science.
[87] R. Klein,et al. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. , 2007, Ophthalmology.
[88] Paul Mitchell,et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.
[89] P. D. de Jong,et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. , 2007, Ophthalmology.
[90] A Hofman,et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. , 2001, Investigative ophthalmology & visual science.
[91] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[92] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.
[93] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[94] T. Rosenberg. Prevalence and causes of blindness in Greenland. , 1987, Arctic medical research.
[95] S. Fliesler,et al. Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.
[96] M. Brown,et al. Modulation of Rhodopsin Function by Properties of the Membrane Bilayer , 2022 .